603716: reply to the inquiry letter on Thalys Medical Technology Group Corporation(603716) abnormal fluctuations in stock trading

603716: reply to the inquiry letter on Thalys Medical Technology Group Corporation(603716) abnormal fluctuations in stock trading Thalys Medical Technology Group Corporation(603716) : I have received the inquiry letter on Thalys Medical Technology Group Corporation(603716) abnormal fluctuations in stock trading. After careful self-examination, my reply on the relevant situation is as follows: up to now, as the actual controller of Thalys Medical Technology Group Corporation(603716) (hereinafter referred to as ” Thalys Medical Technology Group Corporation(603716) “), Because I control the normal business needs of saihai (Shanghai) Health Technology Co., Ltd. (hereinafter referred to as “saihai health”, Thalys Medical Technology Group Corporation(603716) controlling shareholder), introduce institutional investors and improve the governance structure of listed companies, The agreement transfer is under preparation (in the short form equity change report issued and disclosed by saihai health on November 5, 2021, it has been stated that there is a reduction plan in the next 12 months). At present, it is in the negotiation stage, and there is great uncertainty in related matters